Harlow, United Kingdom

Peter Ernest Soden

USPTO Granted Patents = 4 

 

Average Co-Inventor Count = 7.8

ph-index = 3

Forward Citations = 15(Granted Patents)


Location History:

  • Stevenage, GB (2014)
  • Harlow, GB (2012 - 2015)

Company Filing History:


Years Active: 2012-2015

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: The Innovations of Peter Ernest Soden

Introduction

Peter Ernest Soden is a notable inventor based in Harlow, GB. He has made significant contributions to the field of biotechnology, particularly in the development of antibodies related to Alzheimer's disease and other disorders. With a total of 4 patents to his name, Soden's work has the potential to impact the treatment of various diseases characterized by elevated beta-amyloid levels.

Latest Patents

Soden's latest patents include groundbreaking innovations in the realm of antibodies. One of his patents focuses on antibodies that bind human β-amyloid peptide, which are crucial for treating diseases or disorders characterized by elevated β-amyloid levels or deposits. This patent also covers pharmaceutical compositions comprising these antibodies and methods of manufacture. Another significant patent involves humanized anti-beta-amyloid antibodies, which are antigen-binding proteins that specifically target β-amyloid peptide. This innovation aims to address diseases such as Alzheimer's and other conditions affecting the eye or optic nerve, including age-related macular degeneration and glaucoma.

Career Highlights

Peter Soden is currently associated with Glaxo Group Limited, where he continues to advance his research and development efforts. His work at this prominent pharmaceutical company allows him to collaborate with other experts in the field and contribute to innovative solutions in healthcare.

Collaborations

Soden has worked alongside notable colleagues, including Jonathan Henry Ellis and Susannah Karen Ford. Their collaborative efforts have further enhanced the research and development of therapeutic antibodies.

Conclusion

Peter Ernest Soden's contributions to biotechnology and his innovative patents position him as a key figure in the fight against diseases related to β-amyloid. His work not only showcases his expertise but also holds promise for future advancements in medical treatments.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…